Introduction: Erasmus syndrome (ErS) is a rare entity in which Systemic Sclerosis (SSc) develops following exposure to silica, with or without associated silicosis. The objectives of this study were: 1) to evaluate the prevalence of ErS in our SSc cohort; 2) to characterize the cases; 3) to evaluate the clinical and laboratory characteristics of SSc in patients with (Ers) or without silica exposure. Methods: Cross-sectional study. Sociodemographic, clinical and laboratory data were collected from all patients with SSc diagnosed in our department according to ACR/EULAR criteria. Data on professional activity and possible exposure to silica were obtained by phone interview. Results: Among 48 patients with SSc, the prevalence of ErS was 16.7% (8/48). All cases identified were male, corresponding to 72.7% of men with SSc followed at our department. There was a statistically significant association between ErS and male gender (p<0.001), initial pulmonary manifestation (p=0.005), history of digital ulcers (p=0.014) and smoking (p=0.047). A lower risk of gastrointestinal involvement was found in ErS cases (p=0.008). All patients with ErS had positive autoantibodies (mainly anti-Sc170 and anti-centromere) with higher titters than those with SSc with no silica exposition, although this difference was not statistically significant. Although with no statistical significance, we found that pulmonary artery systolic pressure (PASP) estimated by echocardiogram was higher in patients with ErS. Conclusion: In our study, prevalence of ErS was higher than that reported on previous studies. For a more accurate ErS diagnosis it is necessary to be aware of sili- ca exposure, even if for short periods, which may have occurred many years before diagnosis. Significant clinical differences were found between ErS and SSc patients without silica exposure, which can have a relevant impact on diagnosis, treatment and prognosis.